miR-32 functions as a tumor suppressor and directly targets SOX9 in human non-small cell lung cancer

Authors:

Abstract
Purpose: MicroRNA-32 (miR-32) is dysregulated in certain human malignancies and correlates with tumor progression. However, its expression and function in non-small cell lung cancer (NSCLC) remain unclear. Thus, the aim of this study was to explore the effects of miR-32 expression on NSCLC tumorigenesis and development. Methods: Using real-time quantitative reverse-transcription polymerase chain reaction (qRT-PCR), we detected miR-32 expression in NSCLC cell lines and primary tumor tissues. The association of miR-32 expression with clinicopathological factors and prognosis was also analyzed. Then, the effects of miR-32 expression on the biological behavior of NSCLC cells were investigated. Finally, the potential regulatory effect of miR-32 on SOX9 expression was confirmed. Results: miR-32 expression levels were significantly downregulated in NSCLC compared with the corresponding noncancerous lung tissues (PP=0.002), advanced tumor/nodes/metastasis (TNM) classification stages (PPSOX9 was confirmed as a direct target of miR-32, using a luciferase reporter assay. Conclusion: These findings indicate that miR-32 may act as a tumor suppressor in NSCLC and could serve as a novel therapeutic agent for miR-based therapy.

This publication has 33 references indexed in Scilit: